These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 9137790)
21. Results of radiation monotherapy for primary central nervous system lymphoma in the 1990s. Shibamoto Y; Ogino H; Hasegawa M; Suzuki K; Nishio M; Fujii T; Kato E; Ishihara S; Sougawa M; Kenjo M; Kawamura T; Hayabuchi N Int J Radiat Oncol Biol Phys; 2005 Jul; 62(3):809-13. PubMed ID: 15936564 [TBL] [Abstract][Full Text] [Related]
22. High-dose methotrexate with or without whole brain radiotherapy for primary CNS lymphoma (G-PCNSL-SG-1): a phase 3, randomised, non-inferiority trial. Thiel E; Korfel A; Martus P; Kanz L; Griesinger F; Rauch M; Röth A; Hertenstein B; von Toll T; Hundsberger T; Mergenthaler HG; Leithäuser M; Birnbaum T; Fischer L; Jahnke K; Herrlinger U; Plasswilm L; Nägele T; Pietsch T; Bamberg M; Weller M Lancet Oncol; 2010 Nov; 11(11):1036-47. PubMed ID: 20970380 [TBL] [Abstract][Full Text] [Related]
23. Primary central nervous system lymphoma. Results at the University of California at Los Angeles and review of the literature. Selch MT; Shimizu KT; De Salles AF; Sutton C; Parker RG Am J Clin Oncol; 1994 Aug; 17(4):286-93. PubMed ID: 8048389 [TBL] [Abstract][Full Text] [Related]
24. Aberrant methylation in the promoter region of the reduced folate carrier gene is a potential mechanism of resistance to methotrexate in primary central nervous system lymphomas. Ferreri AJ; Dell'Oro S; Capello D; Ponzoni M; Iuzzolino P; Rossi D; Pasini F; Ambrosetti A; Orvieto E; Ferrarese F; Arrigoni G; Foppoli M; Reni M; Gaidano G Br J Haematol; 2004 Sep; 126(5):657-64. PubMed ID: 15327516 [TBL] [Abstract][Full Text] [Related]
25. Therapeutic management of primary CNS lymphoma in immunocompetent patients. Reni M; Ferreri AJ Expert Rev Anticancer Ther; 2001 Oct; 1(3):382-94. PubMed ID: 12113105 [TBL] [Abstract][Full Text] [Related]
26. The Cleveland Clinic experience with primary central nervous system lymphoma. Xie H; Ahluwalia MS; Peereboom DM Am J Clin Oncol; 2015 Apr; 38(2):140-6. PubMed ID: 23608829 [TBL] [Abstract][Full Text] [Related]
27. [Treatment of primary central nervous system lymphoma in the immunocompetent patient]. Sierra Del Rio M; Benouaich-Amiel A; Psimaras D; Dehais C; Hoang-Xuan K Rev Neurol (Paris); 2008; 164(6-7):569-74. PubMed ID: 18565356 [TBL] [Abstract][Full Text] [Related]
28. Primary CNS lymphoma in immunocompetent patients from 1989 to 2001: a retrospective analysis of 164 cases uniformly diagnosed by stereotactic biopsy. Feuerhake F; Baumer C; Cyron D; Illerhaus G; Olschewski M; Tilgner J; Ostertag CB; Volk B Acta Neurochir (Wien); 2006 Aug; 148(8):831-8; discussion 838. PubMed ID: 16791439 [TBL] [Abstract][Full Text] [Related]
29. Treatment of Primary Central Nervous System Lymphoma with High-dose Methotrexate and Radiotherapy in HIV-negative Patients. Jalaeikhoo H; Yekaninejad MS; Hajizamani S; Rahim F; Ahmadzadeh A; Keyhani M; Sadeghi Hariri B; Saki N Arch Iran Med; 2015 Sep; 18(9):577-81. PubMed ID: 26317598 [TBL] [Abstract][Full Text] [Related]
30. Survival improvement with combined radio-chemotherapy in the primary central nervous system lymphomas. Wu HG; Kim IH; Ha SW; Park CI; Bang YJ; Huh DS J Korean Med Sci; 1999 Oct; 14(5):565-70. PubMed ID: 10576154 [TBL] [Abstract][Full Text] [Related]
31. [The clinical analysis of primary central nervous system lymphoma in 23 patients]. Piao YZ; Li P; Liu Q; Li WL Zhonghua Nei Ke Za Zhi; 2011 Nov; 50(11):954-7. PubMed ID: 22333130 [TBL] [Abstract][Full Text] [Related]
32. Current status and future of relapsed primary central nervous system lymphoma (PCNSL). Tyson RM; Siegal T; Doolittle ND; Lacy C; Kraemer DF; Neutwelt EA Leuk Lymphoma; 2003 Apr; 44(4):627-33. PubMed ID: 12769339 [TBL] [Abstract][Full Text] [Related]
33. The prognostic role of CD68 and FoxP3 expression in patients with primary central nervous system lymphoma. Cho H; Kim SH; Kim SJ; Chang JH; Yang WI; Suh CO; Cheong JW; Kim YR; Lee JY; Jang JE; Kim Y; Min YH; Kim JS Ann Hematol; 2017 Jul; 96(7):1163-1173. PubMed ID: 28508176 [TBL] [Abstract][Full Text] [Related]
34. Primary central nervous system lymphomas. Batara JF; Grossman SA Curr Opin Neurol; 2003 Dec; 16(6):671-5. PubMed ID: 14624075 [TBL] [Abstract][Full Text] [Related]
35. Diagnosis and management of primary central nervous system lymphoma. Han CH; Batchelor TT Cancer; 2017 Nov; 123(22):4314-4324. PubMed ID: 28950405 [TBL] [Abstract][Full Text] [Related]
36. Combination chemotherapy and radiotherapy for primary central nervous system lymphoma: Radiation Therapy Oncology Group Study 93-10. DeAngelis LM; Seiferheld W; Schold SC; Fisher B; Schultz CJ; J Clin Oncol; 2002 Dec; 20(24):4643-8. PubMed ID: 12488408 [TBL] [Abstract][Full Text] [Related]
37. Primary CNS lymphoma in children and adolescents: a descriptive analysis from the International Primary CNS Lymphoma Collaborative Group (IPCG). Abla O; Weitzman S; Blay JY; O'Neill BP; Abrey LE; Neuwelt E; Doolittle ND; Baehring J; Pradhan K; Martin SE; Guerrera M; Shah S; Ghesquieres H; Silver M; Betensky RA; Batchelor T Clin Cancer Res; 2011 Jan; 17(2):346-52. PubMed ID: 21224370 [TBL] [Abstract][Full Text] [Related]
38. Patterns of treatment in older adults with primary central nervous system lymphoma. Panageas KS; Elkin EB; Ben-Porat L; Deangelis LM; Abrey LE Cancer; 2007 Sep; 110(6):1338-44. PubMed ID: 17647247 [TBL] [Abstract][Full Text] [Related]